EAS 2019 – Maastricht, Netherlands
MECC Maastricht Convention Center Duboisdomein 5a, Maastricht, NetherlandsThe European Atherosclerosis Society (EAS) and the Dutch Atherosclerosis Society invite you to the 87th EAS Congress in the charming and historic city of Maastricht. The meeting will explore the latest developments in research into the causes of atherosclerosis and related vascular disease, and how these may affect the clinical guidelines for diagnosis and treatment. […]
Novel Pharmacological Treatments for the Prevention of Cardiovascular Events
Novel Pharmacological Treatments for the Prevention of Cardiovascular Events Which agents to use and which patients benefit from the newer interventions? OVERVIEW This webinar focuses on the use of novel […]
Clopidogrel or Ticagrelor: Why, When, for Whom?
Dual antiplatelet therapy (DAPT), consisting of aspirin and a P2Y12 inhibitor, is the cornerstone of the management of acute coronary syndromes. Despite its proven benefits, the choice of P2Y12 inhibitors […]
ACC.23/WCC
The American College of Cardiology joins the World Heart Federation to host ACC.23 Together With WCC (ACC.23/WCC) in New Orleans, LA, March 4 – 6, 2023. Learn more and register […]
Nebivolol: No limb pain?
Beta-blockers are routinely prescribed often as first-line therapy for various cardiovascular diseases such as coronary heart disease and heart failure. Much of their prescribing relates to the benefits of the […]